{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:35Z","timestamp":1761986555503,"version":"3.38.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000069","name":"HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01-AR060962"],"award-info":[{"award-number":["R01-AR060962"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01-AR060962"],"award-info":[{"award-number":["R01-AR060962"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Atopic dermatitis (AD) is a disease of immune dysregulation and skin barrier dysfunction with a relapsing, remitting course and has been associated with several different genetic risk variants. HLA represent a highly variable set of genes that code for cell surface protein molecules involved in the Ag-specific immune response, including the regulation or functioning of T cells, NK cells, and APCs. The purpose of this study was to evaluate associations between HLA class I polymorphisms and the progression of AD over time. We evaluated the associations of AD symptoms and HLA class I polymorphisms based on high-resolution two-field typing in a longitudinal cohort of children with AD (up to 10 y of follow-up). Seven hundred and ninety-two children were evaluated every 6 mo, resulting in 12,752 AD evaluations. Using generalized estimating equations and corrected p values, B*44:02 was found to be associated with AD remission (1.83 [1.35, 2.47]; p = 0.0015). The HLA-B residues at position 116 (d-aspartate) and 80 (T-threonine) were associated with remission (1.42 [1.13, 1.76], p = 0.003; corrected p = 0.028) and (1.45 [1.17, 1.80], p = 0.0008; corrected p = 0.0024), respectively. B80T is a killer-cell Ig-like receptor (KIR) site. Our findings reveal that two axes of immune response (T cell and NK cell) may influence disease progression. Identifying binding pocket changes in addition to other factors (e.g., allergens) that increase the risk or severity of AD can improve our understanding of the immunologic mechanisms associated with AD and may lead to personalized therapies for improving patient care.<\/jats:p>","DOI":"10.4049\/jimmunol.2001252","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T15:06:10Z","timestamp":1618585570000},"page":"2038-2044","source":"Crossref","is-referenced-by-count":9,"title":["HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal Study"],"prefix":"10.1093","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-8085","authenticated-orcid":false,"given":"David J","family":"Margolis","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine , Philadelphia, PA"},{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandita","family":"Mitra","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8100-7161","authenticated-orcid":false,"given":"Brian S","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for the Study of Itch and Sensory Disorders, Division of Dermatology, Department of Medicine, Washington University School of Medicine , St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-0846","authenticated-orcid":false,"given":"Jamie L","family":"Duke","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital of Philadelphia , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-1218","authenticated-orcid":false,"given":"Ron A","family":"Berna","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-903X","authenticated-orcid":false,"given":"Ole J","family":"Hoffstad","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna R","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital of Philadelphia , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-2523","authenticated-orcid":false,"given":"Deborah A","family":"Ferriola","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital of Philadelphia , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9254-6531","authenticated-orcid":false,"given":"Tim L","family":"Mosbruger","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital of Philadelphia , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-3659","authenticated-orcid":false,"given":"Bradley S","family":"Wubbenhorst","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Philadelphia , PA"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-0901","authenticated-orcid":false,"given":"Kathrine L","family":"Nathanson","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Philadelphia , PA"},{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri S","family":"Monos","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital of Philadelphia , Philadelphia, PA"},{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"2025030417494544900_r1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population","volume":"139","author":"Chiesa Fuxench","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"2025030417494544900_r2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","article-title":"Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys","volume":"368","author":"Asher","year":"2006","journal-title":"Lancet"},{"key":"2025030417494544900_r3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamadermatol.2013.10271","article-title":"Persistence of mild to moderate atopic dermatitis","volume":"150","author":"Margolis","year":"2014","journal-title":"JAMA Dermatol."},{"key":"2025030417494544900_r4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jaip.2019.01.005","article-title":"Atopic dermatitis in US adults: from population to health care utilization","volume":"7","author":"Silverberg","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2025030417494544900_r5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: filaggrin","volume":"132","author":"Brown","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"2025030417494544900_r6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00403-019-01956-3","article-title":"Filaggrin sequencing and bioinformatics tools","volume":"312","author":"Margolis","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"2025030417494544900_r7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jamadermatol.2013.7954","article-title":"Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis","volume":"150","author":"Margolis","year":"2014","journal-title":"JAMA Dermatol."},{"key":"2025030417494544900_r8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12016-015-8508-5","article-title":"The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms","volume":"51","author":"Liang","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2025030417494544900_r9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.anai.2019.08.018","article-title":"Association between fine mapping thymic stromal lymphopoietin and atopic dermatitis onset and persistence","volume":"123","author":"Lou","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"2025030417494544900_r10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2025030417494544900_r11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","article-title":"The HLA region and autoimmune disease: associations and mechanisms of action","volume":"8","author":"Gough","year":"2007","journal-title":"Curr. Genomics"},{"key":"2025030417494544900_r12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/ng.3424","article-title":"Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis","volume":"47","author":"Paternoster","year":"2015","journal-title":"Nat. Genet."},{"key":"2025030417494544900_r13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/ng.3424","article-title":"Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis","volume":"47","author":"Australian Asthma Genetics Consortium (AAGC)","year":"2015","journal-title":"Nat. Genet."},{"key":"2025030417494544900_r14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/ng.2438","article-title":"Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population","volume":"44","author":"Hirota","year":"2012","journal-title":"Nat. Genet."},{"key":"2025030417494544900_r15","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2222.2000.00944.x","article-title":"Evidence for a role of HLA DRB1 alleles in the control of IgE levels, strengthened by interacting TCR A\/D marker alleles","volume":"30","author":"Mansur","year":"2000","journal-title":"Clin. Exp. Allergy"},{"key":"2025030417494544900_r16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0091-6749(95)70191-5","article-title":"Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis","volume":"96","author":"Saeki","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417494544900_r17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4168\/aair.2012.4.3.143","article-title":"The HLA-DRB1 polymorphism is associated with atopic dermatitis, but not egg allergy in Korean children","volume":"4","author":"Park","year":"2012","journal-title":"Allergy Asthma Immunol. Res."},{"key":"2025030417494544900_r18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.humimm.2015.08.003","article-title":"Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis","volume":"76","author":"Margolis","year":"2015","journal-title":"Hum. Immunol."},{"key":"2025030417494544900_r19","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1093\/hmg\/ddt317","article-title":"A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis","volume":"22","author":"Weidinger","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"2025030417494544900_r20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ng.1017","article-title":"Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis","volume":"44","author":"Paternoster","year":"2011","journal-title":"Nat. Genet."},{"key":"2025030417494544900_r21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajhg.2014.12.004","article-title":"Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. [Published erratum appears in 2015 Am. J. Hum. Genet. 97: 933.]","volume":"96","author":"Baurecht","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"2025030417494544900_r22","doi-asserted-by":"crossref","first-page":"eaay1005","DOI":"10.1126\/scitranslmed.aay1005","article-title":"Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis","volume":"12","author":"Mack","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"2025030417494544900_r23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2013.00008","article-title":"Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms","volume":"4","author":"Ku\u015bnierczyk","year":"2013","journal-title":"Front. Immunol."},{"key":"2025030417494544900_r24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.gene.2013.06.015","article-title":"Protective effect of the KIR2DS1 gene in atopic dermatitis","volume":"527","author":"Niepiek\u0142o-Miniewska","year":"2013","journal-title":"Gene"},{"key":"2025030417494544900_r25","first-page":"337","article-title":"Decreased natural killer cell activity in atopic eczema","volume":"56","author":"Hall","year":"1985","journal-title":"Immunology"},{"key":"2025030417494544900_r26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaci.2009.11.020","article-title":"Natural killer cells in atopic and autoimmune diseases of the skin","volume":"125","author":"von Bubnoff","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417494544900_r27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jaci.2012.07.008","article-title":"The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort","volume":"130","author":"Margolis","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417494544900_r28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2016.4467","article-title":"Association of filaggrin loss of function and thymic stromal lymphopoietin variation with treatment use in pediatric atopic dermatitis","volume":"153","author":"Chang","year":"2017","journal-title":"JAMA Dermatol."},{"key":"2025030417494544900_r29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamadermatol.2014.4305","article-title":"Association between malignancy and topical use of pimecrolimus","volume":"151","author":"Margolis","year":"2015","journal-title":"JAMA Dermatol."},{"key":"2025030417494544900_r30","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/bjd.15403","article-title":"Cross-sectional comparisons of patient-reported disease control, disease severity and symptom frequency in children with atopic dermatitis","volume":"177","author":"Chang","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"2025030417494544900_r31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"2025030417494544900_r32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bjd.18657","article-title":"Validation of five patient-reported outcomes for atopic dermatitis severity in adults","volume":"182","author":"Silverberg","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"2025030417494544900_r33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00251-015-0849-y","article-title":"Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?","volume":"67","author":"van Deutekom","year":"2015","journal-title":"Immunogenetics"},{"key":"2025030417494544900_r34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol. Opt."},{"key":"2025030417494544900_r35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2009.03208.x","article-title":"The extensive polymorphism of KIR genes","volume":"129","author":"Middleton","year":"2010","journal-title":"Immunology"},{"key":"2025030417494544900_r36","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI98463","article-title":"Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1","volume":"128","author":"Martin","year":"2018","journal-title":"J. Clin. Invest."},{"key":"2025030417494544900_r37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.1402542","article-title":"The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope","volume":"194","author":"Saunders","year":"2015","journal-title":"J. Immunol."},{"key":"2025030417494544900_r38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/imr.12319","article-title":"A bird\u2019s eye view of NK cell receptor interactions with their MHC class I ligands","volume":"267","author":"Saunders","year":"2015","journal-title":"Immunol. Rev."},{"key":"2025030417494544900_r39","doi-asserted-by":"crossref","first-page":"eaag1672","DOI":"10.1126\/sciimmunol.aag1672","article-title":"Class I HLA haplotypes form two schools that educate NK cells in different ways","volume":"1","author":"Horowitz","year":"2016","journal-title":"Sci. Immunol."},{"key":"2025030417494544900_r40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.180.4.1235","article-title":"NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80","volume":"180","author":"Cella","year":"1994","journal-title":"J. Exp. Med."},{"key":"2025030417494544900_r41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.183.3.829","article-title":"Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy","volume":"183","author":"Zerva","year":"1996","journal-title":"J. Exp. Med."},{"key":"2025030417494544900_r42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1074-7613(02)00304-7","article-title":"Optimization of the MHC class I peptide cargo is dependent on tapasin","volume":"16","author":"Williams","year":"2002","journal-title":"Immunity"},{"key":"2025030417494544900_r43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/tan.12955","article-title":"In celebration of Ruggero Ceppellini: HLA in transplantation","volume":"89","author":"Petersdorf","year":"2017","journal-title":"HLA"},{"key":"2025030417494544900_r44","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1182\/blood.V98.10.3150","article-title":"Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain","volume":"98","author":"Ferrara","year":"2001","journal-title":"Blood"},{"key":"2025030417494544900_r45","doi-asserted-by":"crossref","first-page":"e0180831","DOI":"10.1371\/journal.pone.0180831","article-title":"KIR and their HLA class I ligands: two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation","volume":"12","author":"Littera","year":"2017","journal-title":"PLoS One"},{"key":"2025030417494544900_r46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","article-title":"Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations","volume":"132","author":"Campbell","year":"2011","journal-title":"Immunology"},{"key":"2025030417494544900_r47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng2035","article-title":"Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1","volume":"39","author":"Martin","year":"2007","journal-title":"Nat. Genet."},{"key":"2025030417494544900_r48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2019.04.036","article-title":"The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease","volume":"81","author":"Brunner","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025030417494544900_r49","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025030417494544900_r50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2018.08.024","article-title":"Atopic dermatitis in African American patients is TH2\/TH22-skewed with TH1\/TH17 attenuation","volume":"122","author":"Sanyal","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"2025030417494544900_r51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417494544900_r52","doi-asserted-by":"crossref","first-page":"e54558","DOI":"10.7554\/eLife.54558","article-title":"Identifying the immune interactions underlying HLA class I disease associations","volume":"9","author":"Debebe","year":"2020","journal-title":"eLife"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/206\/9\/2038\/61367810\/ji2001252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/206\/9\/2038\/61367810\/ji2001252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T17:50:28Z","timestamp":1741110628000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/206\/9\/2038\/7944627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2001252","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"type":"print","value":"0022-1767"},{"type":"electronic","value":"1550-6606"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2021,5,1]]}}}